Product Overview
British Dragon Sermorelin 5mg is a 5 mg lyophilised vial of sermorelin acetate, a peptide that copies the first twenty-nine amino acids of growth hormone releasing hormone, usually written GHRH(1-29). The parent hormone comes from the hypothalamus and instructs the pituitary to release growth hormone, and this shortened version keeps that message while being easier to handle than the full forty-four amino acid chain. Apothecary preparations under the names Geref and Gerel were used to test pituitary function and to treat childhood deficiency; those products left the market, which is why the peptide now circulates as a research item only.
The important physical fact is how brief the signal is. Perfusion work in rats measured the half-life of the parent fragment at 6.2 minutes, and the clinical texts that still discuss the peptide quote ten to twenty minutes, while no established human value exists. A message that short cannot be sustained by one injection a day, so the growth hormone output arrives as a short pulse followed by hours of nothing. That is the opposite design from the long-acting GHRH analogues, and it is the reason this peptide is usually placed before sleep, when the body's own largest pulse is due anyway.
Two audiences use it. The first is the recovery-minded user who wants their own pituitary to do the work, and who takes it to improve sleep architecture, joint comfort and the quality of rebuilding between sessions, often with a low amount of Somatrobol HGH on the days when a direct supply is wanted. The second is the athlete finishing a heavier phase, who runs the peptide while an oral such as Oxanabol holds the muscle through the diet. Sermorelin is prohibited in sport under WADA class S2, which names GHRH and its analogues directly.
Research Dosing and Reconstitution
The fact base contains no confirmed human dose for athletic use. What follows is the vendor grading for the research material, quoted so the arithmetic can be checked, not offered as a clinical schedule.
| Beginner | The lower vendor amount, injected once daily before sleep over a 12-16 week block |
| Intermediate | Towards 400-500 mcg a day in the vendor description, still a single nightly injection |
| Advanced | At the top of the vendor range; more frequent injections add pulses rather than a steady level |
| Female | No female-specific protocol appears in the sources checked, and the vendor grading is not gender validated |
| Administration | Subcutaneous, fasted, normally at bedtime; 5 mg with 1 mL of bacteriostatic water gives 5 mg/mL, so 500 mcg measures 10 units on a U-100 syringe, and 2 mL halves the concentration to 2.5 mg/mL |
Coverage is easy to misjudge. At 500 mcg a night a single 5 mg vial lasts ten nights, so a twelve-week block needs a box of vials rather than a pair. Mixing to the weaker concentration makes the small amounts easier to measure but shortens the working life of the solution.
Two-Receptor Peptide Blocks
Sermorelin is a GHRH analogue, and the classic partner in this category is a ghrelin-receptor agonist such as ipamorelin, because the two act on different receptors and the responses add rather than duplicate. This manufacturer's peptide line does not currently include a ghrelin agonist, so a two-receptor block would draw the second component from elsewhere. The cards below show how the peptide sits inside the brand's own products instead.
What to Expect
- Sleep and recovery. The first changes people notice come in the first fortnight and are felt rather than measured.
- A pulse, not a plateau. Growth hormone rises for a short period after each injection, so daily administration is the only way to keep repeating the signal.
- Slow body composition drift. Any change in lean tissue or fat accumulates across months of nightly use along a stable diet.
- Joints and skin. Water retention inside connective tissue is sometimes reported as improved comfort, and just as often as stiffness when the dose is too high.
- Limitation. The human half-life is unestablished, so the amount actually needed is a vendor figure rather than a measured target.
- Limitation. The class carries oedema, fluid retention and injection site reactions, and the evidence for combining GHRH with ghrelin agonists in the long term is thin.
- Limitation. Prohibited at all times in sport, so timing a block around testing does not work.
Side Effects and Management
Because the peptide is injected every night, local reactions compete with class effects for the top of this list.
Blocks, Breaks and Follow-Up
There is no crash to manage on this peptide, but there are two habits worth copying: a defined break between blocks and a marker set that can show whether anything changed.
